Dr. Peter Martin | Contributors


Older Patients With Mantle Cell Lymphoma Benefit Most From Individualized Treatment

September 13, 2019

While emerging therapies for mantle cell lymphoma (MCL) continue to shape the treatment landscape, no key standard currently exists, says one expert – particularly for older patients, who benefit most from a treatment approach that has been tailored to fit them and their disease.